IDEAYA Biosciences Inc (IDYA)
40.51
-1.02
(-2.46%)
USD |
NASDAQ |
May 17, 16:00
40.51
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Cash from Investing (TTM): -535.95M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -535.95M |
| December 31, 2023 | -158.46M |
| September 30, 2023 | -56.79M |
| June 30, 2023 | -126.82M |
| March 31, 2023 | 7.878M |
| December 31, 2022 | -33.40M |
| September 30, 2022 | -23.54M |
| June 30, 2022 | -61.16M |
| March 31, 2022 | -123.86M |
| December 31, 2021 | -69.67M |
| September 30, 2021 | -73.81M |
| Date | Value |
|---|---|
| June 30, 2021 | -201.08M |
| March 31, 2021 | -120.71M |
| December 31, 2020 | -146.24M |
| September 30, 2020 | -137.80M |
| June 30, 2020 | 7.34M |
| March 31, 2020 | -12.24M |
| December 31, 2019 | 2.265M |
| September 30, 2019 | 4.954M |
| June 30, 2019 | 48.66M |
| March 31, 2019 | 22.72M |
| December 31, 2018 | -63.18M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-535.95M
Minimum
Mar 2024
48.66M
Maximum
Jun 2019
-90.52M
Average
-65.42M
Median
Cash from Investing (TTM) Benchmarks
| Merck & Co Inc | -13.10B |
| Pfizer Inc | -33.86B |
| Geron Corp | 32.62M |
| Verastem Inc | -12.66M |
| Karyopharm Therapeutics Inc | 62.27M |